BioCentury
ARTICLE | Product Development

Warp Speed makes J&J COVID-19 vaccine program fifth above $1B

BARDA drops funding for IL-6 inhibitors after Phase III misses; plus partnering with Partner

August 6, 2020 1:51 AM UTC

J&J’s manufacturing and delivery deal with HHS and DoD brings to $9.3 billion the amount Operation Warp Speed has committed to COVID-19 vaccines, $1.5 billion of which is now committed to the pharma.

The deal comes a week after Johnson & Johnson (NYSE:JNJ) showed a single shot of Ad26.COV2.S has the potential to generate sterilizing immunity...



Access The Full Article